Estrella Immunopharma (ESLA) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $0.43, -19.63% vs the prior close of $0.54.
- Volume 4.23M shares, 2.5x its 50-day average (heavy).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
ESLA slides 19.6% to $0.43 on 2.5x normal volume. Closed at $0.43, -19.63% vs the prior close of $0.54. Day range $0.42–$0.51, opened at $0.51.
ESLA daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — ESLA slides 19.6% to $0.43 on 2.5x normal volume
- Closed at $0.43, -19.63% vs the prior close of $0.54. Day range $0.42–$0.51, opened at $0.51.
- Volume was 4.23M shares, 2.5x its 50-day average of 1.72M — unusually heavy trading.
- Price is -26.8% vs its 50-day average ($0.59) and -57.7% vs its 200-day average ($1.02).
- 52-week range $0.29–$3.15; today's close sits at 5% of that range, 86.3% below the 52-week high.
Oct 15, 2026 — ESLA jumps 68.2% to $0.54 on 135.3x normal volume
- Closed at $0.54, +68.24% vs the prior close of $0.32. Day range $0.30–$0.85, opened at $0.31.
- Volume was 62.21M shares, 135.3x its 50-day average of 459.68K — unusually heavy trading.
- Price is -9.9% vs its 50-day average ($0.59) and -47.7% vs its 200-day average ($1.02).
- 52-week range $0.29–$3.15; today's close sits at 8% of that range, 83.0% below the 52-week high.
Oct 14, 2026 — ESLA rises 1.3% to $0.32
- Closed at $0.32, +1.27% vs the prior close of $0.31. Day range $0.30–$0.33, opened at $0.31.
- Volume was 198.90K shares, 0.4x its 50-day average of 456.18K — lighter than usual.
- Price is -46.8% vs its 50-day average ($0.60) and -69.0% vs its 200-day average ($1.03).
- 52-week range $0.29–$3.15; today's close sits at 1% of that range, 89.9% below the 52-week high.
Oct 13, 2026 — ESLA slides 4.6% to $0.31, a 52-week low, 8 down days in a row
- Closed at $0.31, -4.56% vs the prior close of $0.33. Day range $0.29–$0.34, opened at $0.33.
- Volume was 319.00K shares, 0.7x its 50-day average of 450.34K.
- Price is -48.2% vs its 50-day average ($0.61) and -69.6% vs its 200-day average ($1.03).
- 52-week range $0.29–$3.15; today's close sits at 1% of that range, 90.0% below the 52-week high.
- That makes 8 straight losses.
Oct 12, 2026 — ESLA slides 19.8% to $0.33, a 52-week low on 2.1x normal volume
- Closed at $0.33, -19.76% vs the prior close of $0.41. Day range $0.32–$0.36, opened at $0.32.
- Volume was 900.00K shares, 2.1x its 50-day average of 432.47K — unusually heavy trading.
- Price is -46.4% vs its 50-day average ($0.61) and -68.4% vs its 200-day average ($1.04).
- 52-week range $0.31–$3.15; today's close sits at 1% of that range, 89.6% below the 52-week high.
- That makes 7 straight losses.
Oct 9, 2026 — ESLA dips 1.9% to $0.41, a 52-week low on 548.6x normal volume
- Closed at $0.41, -1.91% vs the prior close of $0.42. Day range $0.31–$0.44, opened at $0.35.
- Volume was 19.85M shares, 548.6x its 50-day average of 36.18K — unusually heavy trading.
- Price is -34.0% vs its 50-day average ($0.62) and -60.8% vs its 200-day average ($1.05).
- 52-week range $0.31–$3.15; today's close sits at 4% of that range, 87.0% below the 52-week high.
- That makes 6 straight losses.
Oct 8, 2026 — ESLA ends flat (-0.2%) to $0.42, a 52-week low on 2.0x normal volume
- Closed at $0.42, -0.24% vs the prior close of $0.42. Day range $0.36–$0.43, opened at $0.41.
- Volume was 71.10K shares, 2.0x its 50-day average of 34.95K — unusually heavy trading.
- Price is -33.4% vs its 50-day average ($0.63) and -60.2% vs its 200-day average ($1.05).
- 52-week range $0.36–$3.15; today's close sits at 2% of that range, 86.7% below the 52-week high.
- That makes 5 straight losses.
Oct 7, 2026 — ESLA dips 2.3% to $0.42, a 52-week low, 4 down days in a row
- Closed at $0.42, -2.33% vs the prior close of $0.43. Day range $0.41–$0.44, opened at $0.41.
- Volume was 48.90K shares, 1.4x its 50-day average of 34.46K.
- Price is -34.0% vs its 50-day average ($0.63) and -60.4% vs its 200-day average ($1.06).
- 52-week range $0.41–$3.15; today's close sits at 0% of that range, 86.7% below the 52-week high.
- That makes 4 straight losses.
Oct 6, 2026 — ESLA dips 2.5% to $0.43, a 52-week low on 2.1x normal volume
- Closed at $0.43, -2.50% vs the prior close of $0.44. Day range $0.41–$0.46, opened at $0.44.
- Volume was 68.70K shares, 2.1x its 50-day average of 33.41K — unusually heavy trading.
- Price is -33.1% vs its 50-day average ($0.64) and -59.7% vs its 200-day average ($1.06).
- 52-week range $0.41–$3.15; today's close sits at 1% of that range, 86.4% below the 52-week high.
- That makes 3 straight losses.
Oct 5, 2026 — ESLA slides 6.0% to $0.44
- Closed at $0.44, -5.98% vs the prior close of $0.47. Day range $0.44–$0.46, opened at $0.46.
- Volume was 31.10K shares, 0.9x its 50-day average of 34.36K.
- Price is -32.1% vs its 50-day average ($0.65) and -58.8% vs its 200-day average ($1.07).
- 52-week range $0.43–$3.15; today's close sits at 0% of that range, 86.0% below the 52-week high.
Oct 2, 2026 — ESLA dips 1.5% to $0.47
- Closed at $0.47, -1.47% vs the prior close of $0.47. Day range $0.46–$0.51, opened at $0.46.
- Volume was 14.50K shares, 0.4x its 50-day average of 34.24K — lighter than usual.
- Price is -28.5% vs its 50-day average ($0.65) and -56.5% vs its 200-day average ($1.07).
- 52-week range $0.43–$3.15; today's close sits at 1% of that range, 85.1% below the 52-week high.
ESLA latest news & SEC filings
Every SEC filing by or about ESLA in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 8, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
Aug 26, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 25, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 21, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$2.31M (prior year -$5.54M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.05 (prior year -$0.15) (loss narrowed vs Jun 30, 2025)
Jun 30, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Things to know before you trade ESLA
- How much it moves: over the last 20 sessions the average daily move was 8.09% (largest 68.2%). That is a volatile stock.
- Liquidity: about 4.46M shares (≈$1.92M) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.43 vs a range of $0.29–$3.15 (5% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 12 open-market buys, 0 sales; latest: Jiandong Xu bought 1,000 shares on Oct 7, 2025.
- Latest filings: 8-K Sep 8, 2026; 8-K Aug 21, 2026; 10-Q Aug 13, 2026.
- Share count: 43.50M shares outstanding (Aug 11, 2026), +17.4% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Biological Products, (No Diagnostic Substances).
ESLA market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.51 | 0.51 | 0.42 | 0.43 | 4.23M |
| Oct 15, 2026 | 0.31 | 0.85 | 0.30 | 0.54 | 63.11M |
| Oct 14, 2026 | 0.31 | 0.33 | 0.30 | 0.32 | 198.90K |
| Oct 13, 2026 | 0.33 | 0.34 | 0.29 | 0.31 | 319.00K |
| Oct 12, 2026 | 0.32 | 0.36 | 0.32 | 0.33 | 900.00K |
| Oct 9, 2026 | 0.35 | 0.44 | 0.31 | 0.41 | 19.85M |
| Oct 8, 2026 | 0.41 | 0.43 | 0.36 | 0.42 | 71.10K |
| Oct 7, 2026 | 0.41 | 0.44 | 0.41 | 0.42 | 48.90K |
| Oct 6, 2026 | 0.44 | 0.46 | 0.41 | 0.43 | 68.70K |
| Oct 5, 2026 | 0.46 | 0.46 | 0.44 | 0.44 | 31.10K |
| Oct 2, 2026 | 0.46 | 0.51 | 0.46 | 0.47 | 14.50K |
| Oct 1, 2026 | 0.46 | 0.48 | 0.46 | 0.47 | 14.40K |
| Sep 30, 2026 | 0.50 | 0.50 | 0.46 | 0.47 | 18.40K |
| Sep 29, 2026 | 0.47 | 0.49 | 0.44 | 0.46 | 26.10K |
| Sep 28, 2026 | 0.47 | 0.50 | 0.43 | 0.43 | 36.00K |
| Sep 25, 2026 | 0.47 | 0.50 | 0.47 | 0.48 | 27.80K |
| Sep 24, 2026 | 0.47 | 0.50 | 0.47 | 0.47 | 9.20K |
| Sep 23, 2026 | 0.47 | 0.50 | 0.46 | 0.47 | 32.30K |
| Sep 22, 2026 | 0.55 | 0.56 | 0.48 | 0.49 | 62.60K |
| Sep 21, 2026 | 0.53 | 0.58 | 0.50 | 0.50 | 52.00K |
About Estrella Immunopharma
Estrella Immunopharma (ESLA) is listed on the Nasdaq and classified by the SEC under “Biological Products, (No Diagnostic Substances)”. Its business address is in EMERYVILLE, CA. Fiscal year ends December 31. SEC CIK 1844417.
ESLA board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Dengyao Jia | Director | Oct 1, 2025 |
| Cheng Liu | CEO | Aug 26, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Cheng Liu | CEO | Aug 26, 2026 |
| Jiandong Xu | Chief Financial Officer | Aug 25, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Oct 7, 2025 | Jiandong Xu | Buy | 1,000 | $1.33 |
| Oct 7, 2025 | Jiandong Xu | Buy | 1,000 | $1.33 |
| Oct 7, 2025 | Jiandong Xu | Buy | 1,000 | $1.33 |
| Oct 7, 2025 | Jiandong Xu | Buy | 1,000 | $1.33 |
| Sep 22, 2025 | Jiandong Xu | Buy | 1,000 | $1.16 |
| Sep 22, 2025 | Jiandong Xu | Buy | 1,000 | $1.16 |
| Sep 22, 2025 | Jiandong Xu | Buy | 1,000 | $1.16 |
| Sep 22, 2025 | Jiandong Xu | Buy | 1,000 | $1.16 |
| Sep 11, 2025 | Jiandong Xu | Buy | 100 | $1.04 |
| Sep 11, 2025 | Jiandong Xu | Buy | 100 | $1.04 |
| Sep 11, 2025 | Jiandong Xu | Buy | 100 | $1.04 |
| Sep 11, 2025 | Jiandong Xu | Buy | 100 | $1.04 |
ESLA financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-13.06M | -0.35 | $-1.79M |
| Jun 30, 2024 | — | $-7.31M | -0.27 | $-16.07M |
| Jun 30, 2023 | — | $-11.11M | -36.35 | $-1.34M |
| Dec 31, 2022 | — | $-996.10K | — | $-1.04M |
| Dec 31, 2021 | — | $-247.72K | — | $-316.16K |
Latest balance sheet: total assets $1.82M, total liabilities $9.26M, cash $100.00K (as of Jun 30, 2026).
ESLA earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)Kodiak Sciences (KOD)Greenland Mines (GRML)Halozyme Therapeutics (HALO)Biogen (BIIB)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on ESLA
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.